VAERS reports by lot

GSK DTaP/Tdap lot BR352: VAERS reports

30 VAERS reports list lot BR352 as a GSK DTaP/Tdap vaccine, received between 2020-04-28 and 2023-09-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
3%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1421%
Neurological1218%
Musculoskeletal913%
Injection-site / Local reaction913%
Cardiac / Cardiovascular812%
Dermatological (non-injection-site)69%
Allergic / Anaphylactic57%
Thrombotic / Hematological23%
Gastrointestinal23%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Idaho2
Washington2
New York2
Puerto Rico1
Kansas1
Colorado1
Texas1
New Mexico1
Wisconsin1
Indiana1
Tennessee1

Reports by month received

2020-041
2020-053
2020-062
2020-073
2020-082
2020-092
2020-111
2021-011
2021-042
2021-061
2021-071
2021-092
2021-111
2021-126
2022-091
2023-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.